Akari Therapeutics

NASDAQ: AKTX · Real-Time Price · USD
1.16
0.07 (6.42%)
At close: Jun 17, 2025, 3:59 PM
1.20
3.90%
After-hours: Jun 17, 2025, 07:59 PM EDT

Akari Therapeutics Revenue

Akari Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Akari Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
8
Market Cap
18.58K

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.